| 1 |
35566132 | Nicotinic Acetylcholine Receptors and Microglia as Therapeutic and Imaging Targets in Alzheimer's Disease. | 2022 Apr 27 |
2 |
| 2 |
33252082 | Multi-Target Effects of the Cannabinoid CP55940 on Familial Alzheimer's Disease PSEN1 E280A Cholinergic-Like Neurons: Role of CB1 Receptor. | 2021 |
1 |
| 3 |
33571523 | Selective coactivation of α7- and α4β2-nicotinic acetylcholine receptors reverses beta-amyloid-induced synaptic dysfunction. | 2021 Jan-Jun |
1 |
| 4 |
33862141 | Integrated phylogeny of the human brain and pathobiology of Alzheimer's disease: A unifying hypothesis. | 2021 Jun 11 |
2 |
| 5 |
34733055 | DMSO Delays Alzheimer Disease Causing Aβ-induced Paralysis in C. elegans Through Modulation of Glutamate/Acetylcholine Neurotransmission. | 2021 Jan |
1 |
| 6 |
32582986 | Expression levels of the α7 nicotinic acetylcholine receptor in the brains of patients with Alzheimer's disease and their effect on synaptic proteins in SH-SY5Y cells. | 2020 Sep |
1 |
| 7 |
33042734 | A Novel Targeted and High-Efficiency Nanosystem for Combinational Therapy for Alzheimer's Disease. | 2020 Oct |
1 |
| 8 |
30800059 | Molecular Modulation of Human α7 Nicotinic Receptor by Amyloid-β Peptides. | 2019 |
1 |
| 9 |
31417354 | Homomeric and Heteromeric Aβ Species Exist in Human Brain and CSF Regardless of Alzheimer's Disease Status and Risk Genotype. | 2019 |
4 |
| 10 |
31934215 | The expression of the nicotinic acetylcholine receptor α3 subunit in the brains of patients with Alzheimer's disease and its effects on α- and γ-secretases and Notch signal transduction in SH-SY5Y cells. | 2019 |
1 |
| 11 |
28993924 | Effects of Acetylcholine on β-Amyloid-Induced cPLA2 Activation in the TB Neuroectodermal Cell Line: Implications for the Pathogenesis of Alzheimer's Disease. | 2018 May |
6 |
| 12 |
27719660 | Neuroprotective and Neurotoxic Implications of α7 Nicotinic Acetylcholine Receptor and Aβ Interaction: Therapeutic Options in Alzheimer's Disease. | 2017 |
2 |
| 13 |
28074940 | Alpha7 nicotinic acetylcholine receptor is required for amyloid pathology in brain endothelial cells induced by Glycoprotein 120, methamphetamine and nicotine. | 2017 Jan 11 |
1 |
| 14 |
26293308 | Immunohistochemical analysis of hippocampal butyrylcholinesterase: Implications for regional vulnerability in Alzheimer's disease. | 2016 Apr |
1 |
| 15 |
26861273 | Novel Triazole-Quinoline Derivatives as Selective Dual Binding Site Acetylcholinesterase Inhibitors. | 2016 Feb 5 |
1 |
| 16 |
27402297 | β-Amyloid-acetylcholine molecular interaction: new role of cholinergic mediators in anti-Alzheimer therapy? | 2016 Jul |
2 |
| 17 |
25004204 | Adipose and leptomeningeal arteriole endothelial dysfunction induced by β-amyloid peptide: a practical human model to study Alzheimer's disease vasculopathy. | 2014 Sep 30 |
4 |
| 18 |
23022323 | Modeling the binding mechanism of Alzheimer's Aβ1-42 to nicotinic acetylcholine receptors based on similarity with snake α-neurotoxins. | 2013 Jan |
2 |
| 19 |
23036017 | Pathogenesis of Abeta oligomers in synaptic failure. | 2013 Mar |
1 |
| 20 |
24292188 | [Molecular targeting and translational research for new therapeutic strategies on Alzheimer's disease]. | 2013 |
2 |
| 21 |
21683475 | Different β-amyloid oligomer assemblies in Alzheimer brains correlate with age of disease onset and impaired cholinergic activity. | 2012 Apr |
1 |
| 22 |
22261393 | Neuronal receptors as targets for the action of amyloid-beta protein (Aβ) in the brain. | 2012 Jan 20 |
1 |
| 23 |
22300028 | α7 nicotinic acetylcholine receptors in Alzheimer's disease: neuroprotective, neurotrophic or both? | 2012 May |
1 |
| 24 |
22402892 | Cerebrospinal fluid levels of Aβ42 relationship with cholinergic cortical activity in Alzheimer's disease patients. | 2012 Jul |
1 |
| 25 |
24052808 | Synthesis and in silico evaluation of 1N-methyl-1S-methyl-2-nitroethylene (NMSM) derivatives against Alzheimer disease: to understand their interacting mechanism with acetylcholinesterase. | 2012 |
2 |
| 26 |
21116052 | Functional interactions of fibrillar and oligomeric amyloid-β with alpha7 nicotinic receptors in Alzheimer's disease. | 2011 |
1 |
| 27 |
20847424 | Amyloid-β as a modulator of synaptic plasticity. | 2010 |
1 |
| 28 |
19355845 | M1 agonists as a potential disease-modifying therapy for Alzheimer's disease. | 2009 Apr |
1 |
| 29 |
19726654 | Dissociating beta-amyloid from alpha 7 nicotinic acetylcholine receptor by a novel therapeutic agent, S 24795, normalizes alpha 7 nicotinic acetylcholine and NMDA receptor function in Alzheimer's disease brain. | 2009 Sep 2 |
1 |
| 30 |
17007734 | Neuronal nicotinic acetylcholine receptors serve as sensitive targets that mediate beta-amyloid neurotoxicity. | 2006 Oct |
1 |
| 31 |
15599613 | The acetylcholine innervation of cerebral cortex: new data on its normal development and its fate in the hAPP(SW,IND) mouse model of Alzheimer's disease. | 2005 Jan |
1 |
| 32 |
15544502 | An overview of the current and novel drugs for Alzheimer's disease with particular reference to anti-cholinesterase compounds. | 2004 |
1 |
| 33 |
12557749 | Amyloid beta-peptide 25-35 reduces [3H]acetylcholine release in retinal neurons. Involvement of metabolic dysfunction. | 2002 Dec |
3 |
| 34 |
10771022 | Modulation of beta-amyloid precursor protein processing and tau phosphorylation by acetylcholine receptors. | 2000 Mar 30 |
1 |
| 35 |
9562476 | Possible role of tau protein kinases in pathogenesis of Alzheimer's disease. | 1998 Jan-Feb |
1 |
| 36 |
9335413 | Beta-amyloid-induced coronary artery vasoactivity and endothelial damage. | 1997 Oct |
1 |
| 37 |
8651643 | A beta-subunit mutation in the acetylcholine receptor channel gate causes severe slow-channel syndrome. | 1996 Jun |
1 |
| 38 |
8239317 | Abnormalities in brain glucose utilization and its impact on cellular and molecular mechanisms in sporadic dementia of Alzheimer type. | 1993 Sep 24 |
1 |
| 39 |
1377855 | Amyloid beta protein precursors with kunitz-type inhibitor domains and acetylcholinesterase in cerebrospinal fluid from patients with dementia of the Alzheimer type. | 1992 May |
1 |